Japanese firm to start human clinical tests for COVID-19 medicine in 2021

WorldNews

Published

TOKYO, Aug. 25 (Xinhua) -- A biotechnology company in southwestern Japan said Tuesday it will start human clinical trials for a drug of treating COVID-19 in 2021. Bonac Corp., a startup based in Kurume, Fukuoka...

Full Article